Navigation Links
Sting & Paul Simon Concert Tour Tickets in Denver, Seattle, Sunrise, Detroit, DC, Tampa, Houston, St Paul & Dallas Are in High Demand According to Ticket Down

New York, NY (PRWEB) November 17, 2013

Ticket Down announces that concert tickets for Sting and Paul Simon go on sale to the public on Monday, November 18th in Denver, Seattle, Detroit, Sunrise, Washington DC, Houston, St. Paul, Dallas and Tampa.

Two of the most respected and appreciated artists in the music business will be hitting the road together in 2014. The 18-date tour beginning on February 8th and ending on March 16th will feature Sting and Paul Simon. The two will perform their own songs and have even promised a few duets. This isn't the first time the two men have performed together, but it is the first time they will hold a full-blown tour together. The two previously performed at a benefit for the Robin Hood Foundation, which is where the idea for this tour came to fruition.

Sting has released 11 solo studio albums in his career after a lengthy and highly successful career with The Police. Sting, of Wallsend, Northumberland, England in the United Kingdom, has spent much of his career at the top of the music charts with his singles and albums. He has had nine albums reach the top 10 charts in the United States and two of those albums have reached the top spot in the United Kingdom. His albums have been very popular in Austria and the former The Police front man has had numerous singles reach the top of the charts around the world. Among his most popular songs are "All For Love," a song he sang with Bryan Adams and Rod Stewart; "It's Probably Me," with Eric Clapton; and "Desert Rose," with Cheb Mami.

His partner on this tour, Simon, has been in the music business since the 1960s when he was a part of Simon & Garfunkel. The duo released five studio albums and four live albums and was one of the most successful acts in the music business throughout their time together. Their last album, Bridge Over Troubled Water, went platinum eight times in the United States and reached platinum status in several other countries including Canada, France and United Kingdom. As a solo artist, Simon has released 11 albums as a solo artist, including six that reached the top 10 charts and one, Still Crazy After All These Years, which reached the top spot in the United States.

The Simon and Sting tour will begin at the Toyota Center in Houston, Texas; and end at the Amway Center in Orlando, Florida. The tour will also make stops at the Pepsi Center in Denver, Colorado; The Palace of Auburn Hills in Detroit, Michigan; Verizon Center in Washington, D.C., and a date at the world famous Madison Square Garden in New York, New York.

Tickets for Paul Simon and Sting are available now and fans of either man will enjoy the show these two musical legends will give. Aside from playing their songs as solo artists, the two men will surely take to the stage together to wow fans around the United States.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Psychological testing may predict success in soccer
2. DNA Testing Finds Allergens, Toxins in Traditional Chinese Medicines
3. Animals More Interesting to Kids Than Toys, Study Shows
4. Adjusting Your Attitude About Chronic Pain May Help You Sleep
5. Genetically modified T cell therapy shown to be safe, lasting in decade-long study of HIV patients
6. U.S. Obesity Rate Set to Soar, Costing Billions: CDC
7. OHSU study: Misdiagnosis of MS is costing health system millions per year
8. John Theurer Cancer Center hosting 8th Annual Neuro-Oncology Symposium
9. Surgeon General receives 2012 Distinguished Public Service Award from internal medicine physicians
10. Sleep apnea persisting into teens can impact life skills, study finds
11. Marker distinguishes more-aggressive from less-aggressive forms of chronic leukemia
Post Your Comments:
(Date:9/19/2017)... ... September 19, 2017 , ... ... its executive team as the President of its HealthBI division. McFarland will ... and contact centers. , “Scott is a utility player who balances his ...
(Date:9/19/2017)... ... September 19, 2017 , ... MelaKids, a Laredo-based company, has introduced a ... When we’re born, Nature gives us a full supply of melanin – in the ... lose this natural glare-reducing pigment; however, around the age of thirty, we develop a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... the present, Mirixa Corporation recently unveiled the MirixaPro 6.0 platform. As the ... how medication management services are delivered. Based on industry research and market ...
(Date:9/19/2017)... ... September 19, 2017 , ... Back Pain Centers of ... back pain with a reputable physician in their area, announces the addition of ... as Nevada Spine Clinic was founded by board-certified spine surgeon, Jaswinder Grover, M.D. ...
(Date:9/19/2017)... ... 2017 , ... The ISO 9001 standard sets out the requirements for a ... and improve customer satisfaction. ISO 9001:2015 was released in 2015 and certified organizations have ... September 2018. , As described in this white paper , ISO ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
Breaking Medicine Technology: